Beyond Morphology: The ACAT Framework for Biology-Driven Prognostic Assessment in Hepatocellular carcinoma

This preprint introduces the ACAT framework, a novel biology-driven approach for prognostic assessment in hepatocellular carcinoma (HCC). Unlike traditional morphology-based methods, ACAT integrates tumor biology, molecular markers, and clinical parameters to deliver more accurate and reproducible predictions of patient outcomes. This framework is designed to: Enhance prognostic accuracy for HCC patients. Support personalized clinical decision-making. Facilitate open scientific collaboration by providing an accessible, reproducible methodology. Note: This work is a preprint and has not yet been peer-reviewed. Keywords: hepatocellular carcinoma, ACAT framework, prognosis, biomarker, cancer biology, preprint, translational research

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-02-14
DOI
https://doi.org/10.5281/zenodo.18640280
Primary Topic
Hepatocellular Carcinoma Treatment and Prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Beyond Morphology: The ACAT Framework for Biology-Driven Prognostic Assessment in Hepatocellular carcinoma

Jihan Tambal Tambal
Zenodo (CERN European Organization for Nuclear Research)
Hepatocellular Carcinoma Treatment and Prognosis
article

Beyond Morphology: The ACAT Framework for Biology-Driven Prognostic Assessment in Hepatocellular carcinoma

Jihan Tambal Tambal
article en

Abstract

This preprint introduces the ACAT framework, a novel biology-driven approach for prognostic assessment in hepatocellular carcinoma (HCC). Unlike traditional morphology-based methods, ACAT integrates tumor biology, molecular markers, and clinical parameters to deliver more accurate and reproducible predictions of patient outcomes. This framework is designed to: Enhance prognostic accuracy for HCC patients. Support personalized clinical decision-making. Facilitate open scientific collaboration by providing an accessible, reproducible methodology. Note: This work is a preprint and has not yet been peer-reviewed. Keywords: hepatocellular carcinoma, ACAT framework, prognosis, biomarker, cancer biology, preprint, translational research

Zenodo (CERN European Organization for Nuclear Research)
Oldham Council (GB)
Peace, Justice and strong institutions
Openalex Percentile: Top 54%
Hepatocellular Carcinoma Treatment and Prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Beyond Morphology: The ACAT Framework for Biology-Driven Prognostic Assessment in Hepatocellular carcinoma — Jihan Tambal Tambal · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS